✦ LIBER ✦

Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

✍ Scribed by Christoph Varenhorst; Stefan James; David Erlinge; Oscar Ö. Braun; John T. Brandt; Kenneth J. Winters; Joseph A. Jakubowski; Sylvia Olofsson; Lars Wallentin; Agneta Siegbahn

Book ID: 116191664
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 524 KB
Volume: 157
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2008.11.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monitoring platelet inhibition after clo

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study

✍ Alex Malinin; Alex Pokov; Malcolm Spergling; Anthony Defranco; Kenneth Schwartz; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Randomized comparison of new dual-antipl

Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI

✍ Yang, Tae-Hyun; Jin, Han-Young; Choi, Kyu-Nam; Do, Ungjeong; Kim, Hyung Jun; Chu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 463 KB

A Comparison of INNOVANCE® PFA P2Y and V

A Comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 Assay for the Assessment of Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention

✍ Jiyoung Jang; Jihyang Lim; Kiyuk Chang; Yonggoo Kim; Myungshin Kim; Hae il Park; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

EVALUATION OF PLATELET INHIBITION WITH P

EVALUATION OF PLATELET INHIBITION WITH POINT-OF-CARE DEVICE VERIFYNOW IN CHINESE PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL AND PRASUGREL: A PROSPECTIVE COHORT STUDY

✍ Chor Cheung Tam; Hon Wah Raymond Chan; Shun Ling Kong; Linda Lam; Arthur Yung; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Evaluation of platelet inhibition with p

Evaluation of platelet inhibition with point-of-care device VerifyNow in Chinese patients with acute coronary syndrome treated with clopidogrel and prasugrel: a prospective cohort study

✍ Tam, C.C.; Chan, R.H.W.; Kong, S.L.; Lam, L.; Chan, K.W.; Lam, C.C.; Chan, P.H.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Antiplatelet effect of clopidogrel in pa

Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions – Limited inhibition of the P2Y12 receptor

✍ Aino Lepäntalo; Kari S. Virtanen; Julio C. Reséndiz; Jussi Mikkelsson; Leena E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 285 KB